Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Krug

Showing results (1-10 of 198) with videos related to

Pageof 20
Sort By:
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|September 17, 2015
[Regional nodal irradiation in early-stage breast cancer with 0-3 positive nodes]David Krug
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|November 14, 2014
[Not Available]David Krug
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|January 23, 2016
[Cardiotoxicity of trastuzumab in the adjuvant treatment of breast cancer patients : Results of the NCCTG N9831 trial]David Krug
Breast Care (Basel, Switzerland)|May 14, 2020
Adjuvant Radiotherapy for Breast Cancer: More than Meets the EyeDavid Krug
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|December 7, 2015
[Accelerated partial breast irradiation using interstitial multicatheter brachytherapy: A valid treatment option for breast cancer patients with a low-risk profile?]David Krug
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|September 12, 2023
[Moderate hypofractionated adjuvant radiotherapy with simultaneous integrated boost for breast cancer]David Krug, Jürgen Dunst
International Journal of Radiation Oncology, Biology, Physics|February 5, 2025
BRCAness Identifies Synthetic Cytotoxicity Between Cisplatin and Radiation TherapyKerstin Borgmann, David Krug
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|October 20, 2022
[Boost and hypofractionation in DCIS]Jürgen Dunst, David Krug
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|April 20, 2019
[Whole- or partial-breast radiotherapy after 5 years from a patient perspective: longitudinal analysis of the IMPORT LOW (CRUK/06/003) phase III trial]David Krug, Jürgen Dunst
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|April 16, 2016
[Omission of adjuvant radiotherapy in ductal carcinoma in situ : 12 year-results of the ECOG-ACRIN E5194-trial]David Krug, Rainer Souchon
Pageof 20

Showing results (1-10 of 198) with videos related to

Sort By:
Pageof 20
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|September 17, 2015
[Regional nodal irradiation in early-stage breast cancer with 0-3 positive nodes]David Krug
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|November 14, 2014
[Not Available]David Krug
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|January 23, 2016
[Cardiotoxicity of trastuzumab in the adjuvant treatment of breast cancer patients : Results of the NCCTG N9831 trial]David Krug
Breast Care (Basel, Switzerland)|May 14, 2020
Adjuvant Radiotherapy for Breast Cancer: More than Meets the EyeDavid Krug
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|December 7, 2015
[Accelerated partial breast irradiation using interstitial multicatheter brachytherapy: A valid treatment option for breast cancer patients with a low-risk profile?]David Krug
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|September 12, 2023
[Moderate hypofractionated adjuvant radiotherapy with simultaneous integrated boost for breast cancer]David Krug, Jürgen Dunst
International Journal of Radiation Oncology, Biology, Physics|February 5, 2025
BRCAness Identifies Synthetic Cytotoxicity Between Cisplatin and Radiation TherapyKerstin Borgmann, David Krug
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|October 20, 2022
[Boost and hypofractionation in DCIS]Jürgen Dunst, David Krug
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|April 20, 2019
[Whole- or partial-breast radiotherapy after 5 years from a patient perspective: longitudinal analysis of the IMPORT LOW (CRUK/06/003) phase III trial]David Krug, Jürgen Dunst
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|April 16, 2016
[Omission of adjuvant radiotherapy in ductal carcinoma in situ : 12 year-results of the ECOG-ACRIN E5194-trial]David Krug, Rainer Souchon
Pageof 20